Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Inovio

Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances

Inovio Pharmaceuticals (NASDAQ:INO) shareholders approved all proposals presented at the company’s 2026 annual meeting, including the election of eight directors and the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the year ending Dec. 31,

MarketBeat · May 25

5 Analyst-Approved Stocks Set to Join the Russell Microcap Index

As a part of the annual Russell index rebalancing, here are five stocks set to join the Russell Microcap Index this year, which analysts have tagged with consensus ‘buy’ ratings.

Barchart · Jun 6, 2024

Why Inovio Pharmaceuticals Stock Is Rising Today

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher Monday amid increasing monkeypox concerns.

Benzinga · May 23, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

6 Stocks To Watch Amid Monkeypox Outbreak

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.

Benzinga · May 20, 2022

Why Are Inovio Shares Plummeting Today

Joseph Kim, the longtime CEO of Inovio Pharmaceuticals Inc (NASDAQ:INO), is stepping down to make room for Jacqueline Shea, who first joined Inovio as COO in 2019. Shea will be overseeing a change in direction as Inovio, a laggard in the COVID-19 vaccine race, has closed a Phase 3 trial in favor of a…

Benzinga · May 11, 2022

Lab Study Shows Inovio's COVID-19 Vaccine Candidate Weaker Against Omicron Variant

Tucked in the Q4 earnings release, Inovio Pharmaceuticals Inc (NASDAQ: INO) has paused enrollment for an ongoing INNOVATE Phase 3 trial of its lead COVID-19 vaccine candidate.

Benzinga · Mar 2, 2022

Thinking About Buying Stock In AMC Entertainment, Romeo Power Or Inovio Pharmaceuticals?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Benzinga · Feb 24, 2022

Read news from The Economist, FT, and more,
with one subscription

Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals

Following the recent pullback in Inovio Pharmaceuticals Inc.’s (NASDAQ: INO) shares, the stock valuation seems to have been stripped of most of the remaining COVID-19 value, according to BofA Securities.

Benzinga · Jan 21, 2022

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.